RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024 - Seite 3

Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312382109/en/

The RenovoRx Stock at the time of publication of the news with a fall of -3,13 % to 1,700USD on Nasdaq stock exchange (12. März 2024, 01:00 Uhr).